Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Flemming Ornskov
Pharma
Ex-Shire CEO Ornskov emerges as Galderma chief after Nestlé spin
Flemming Ornskov, Shire’s most recent CEO and who orchestrated the Baxalta takeover and later the selloff to Takeda, is now Galderma's CEO.
Angus Liu
Oct 8, 2019 11:42am
Hey, Shire, how big is too big for a CEO bonus target?
Apr 18, 2018 11:37am
Shire CEO sees Microsoft tie-up as outgrowth of digital mission
Mar 21, 2018 10:25am
Shire splits ops to prep neuro biz for sale or spinoff
Jan 8, 2018 10:19am
New threat to Shire's hemophilia biz? Its CEO's not worried
Dec 13, 2017 11:03am
Why are Shire shares down? Investors just don't understand: CEO
Dec 12, 2017 12:09pm
